Brainomix
Brainomix is a pioneering company spun out from the University of Oxford, specializing in AI-powered medical imaging solutions. Their mission is to revolutionize healthcare by transforming scans into actionable insights, aiding in accurate diagnosis and effective treatment planning. Their flagship Brainomix 360 platform is the most comprehensive stroke imaging solution trusted worldwide, and they are expanding into areas such as lung disease and cancer. The company collaborates globally with healthcare institutions and industry partners to enhance patient outcomes through innovative AI technology.
Industries
Nr. of Employees
small (1-50)
Brainomix
Oxford, Oxfordshire, United Kingdom, Europe
Products
Automated stroke imaging analysis platform
Automated multimodality imaging analysis for acute stroke (NCCT, CTA, CTP, MRI) providing ASPECTS scoring, ischemic core and infarct volume quantification, LVO detection, collateral assessment, and triage notifications.
Automated ILD imaging analysis platform
AI-powered imaging solution for quantitative assessment of interstitial lung disease with classifiers and imaging biomarkers to support clinical trials and patient stratification.
Automated solid tumour imaging analysis for oncology trials
Imaging analysis for solid tumour quantification and classifier-based endpoints to support patient selection and efficacy assessment in oncology clinical trials.
Real-time triage and LVO notification service
Service providing real-time alerts for suspected large vessel occlusion and stroke cases to accelerate transfer and treatment decisions.
Automated stroke imaging analysis platform
Automated multimodality imaging analysis for acute stroke (NCCT, CTA, CTP, MRI) providing ASPECTS scoring, ischemic core and infarct volume quantification, LVO detection, collateral assessment, and triage notifications.
Automated ILD imaging analysis platform
AI-powered imaging solution for quantitative assessment of interstitial lung disease with classifiers and imaging biomarkers to support clinical trials and patient stratification.
Automated solid tumour imaging analysis for oncology trials
Imaging analysis for solid tumour quantification and classifier-based endpoints to support patient selection and efficacy assessment in oncology clinical trials.
Real-time triage and LVO notification service
Service providing real-time alerts for suspected large vessel occlusion and stroke cases to accelerate transfer and treatment decisions.
Services
Clinical validation and evidence generation
Support for multicenter validation studies, statistical analysis, and publication of peer-reviewed evidence to evaluate imaging biomarkers and decision-support algorithms.
Clinical deployment and workflow integration
Implementation and integration of automated imaging analysis into hospital workflows, telemedicine networks, and cloud systems to enable real-time triage, notifications, and transfer coordination.
Life-sciences imaging support for trials
Provision of standardized imaging endpoints, automated classifiers, and imaging core-lab services to support patient selection and efficacy assessment in clinical trials for pulmonary and oncology indications.
Implementation and pathway optimization evaluation
Design and conduct of real-world observational evaluations to measure the impact of imaging decision-support deployment on clinical pathways and patient outcomes.
Clinical validation and evidence generation
Support for multicenter validation studies, statistical analysis, and publication of peer-reviewed evidence to evaluate imaging biomarkers and decision-support algorithms.
Clinical deployment and workflow integration
Implementation and integration of automated imaging analysis into hospital workflows, telemedicine networks, and cloud systems to enable real-time triage, notifications, and transfer coordination.
Life-sciences imaging support for trials
Provision of standardized imaging endpoints, automated classifiers, and imaging core-lab services to support patient selection and efficacy assessment in clinical trials for pulmonary and oncology indications.
Implementation and pathway optimization evaluation
Design and conduct of real-world observational evaluations to measure the impact of imaging decision-support deployment on clinical pathways and patient outcomes.
Expertise Areas
- Clinical trial imaging endpoints and patient selection
- Automated imaging biomarker quantification
- AI-driven medical imaging for acute stroke
- Clinical validation and multicenter study support
Key Technologies
- Deep learning for CT and MRI image analysis
- Convolutional neural networks (CNNs)
- Automated volumetric segmentation
- CT perfusion parametric mapping